MECP2 and Rett syndrome: Monogenic models of ASD, such as Fragile X Syndrome (FXS) Fmr1 mutant mice, Tuberous Sclerosis Complex (TSC) TSC1 or TSC2 mutant mice and Rett Syndrome Mecp2 mutant mice, provide good construct validity for exploring potential therapeutic avenues.